Robert Benjamin Stein Mimedx Group, Inc. (MDXG) insider trading activity

Robert Benjamin Stein is President, Regenerative Med. of MIMEDX GROUP, INC.. Currently has a direct ownership of 317,803 shares of MDXG, which is worth approximately $2.75 Million. The most recent transaction as insider was on May 16, 2023, when has been sold 10,365 shares (Common Stock) at a price of $5.95 per share, resulting in proceeds of $61,671. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 318K

0% 3M change

0% 12M change

Total Value Held $2.75 Million

Robert Benjamin Stein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2023	SELL Open market or private sale	$61,671 $5.95 p/Share	10,365 Reduced 3.16%	317,803 Common Stock
May 15 2023	SELL Open market or private sale	$22,183 $6.15 p/Share	3,607 Reduced 1.09%	328,168 Common Stock
May 10 2023	SELL Open market or private sale	$34,803 $5.93 p/Share	5,869 Reduced 1.74%	331,775 Common Stock
May 04 2023	SELL Open market or private sale	$276,377 $5.34 p/Share	51,756 Reduced 13.29%	337,644 Common Stock
Apr 25 2023	SELL Open market or private sale	$22,391 $3.74 p/Share	5,987 Reduced 1.51%	389,400 Common Stock
Apr 11 2023	SELL Open market or private sale	$19,846 $3.31 p/Share	5,996 Reduced 1.49%	395,387 Common Stock
Mar 13 2023	BUY Grant, award, or other acquisition	$624,000 $4.62 p/Share	135,065 Added 25.18%	401,383 Common Stock
Mar 07 2023	SELL Open market or private sale	$52,385 $4.24 p/Share	12,355 Reduced 4.43%	266,318 Common Stock
Sep 13 2022	SELL Open market or private sale	$28,818 $3.46 p/Share	8,329 Reduced 2.9%	278,673 Common Stock
Sep 12 2022	SELL Open market or private sale	$65,360 $3.44 p/Share	19,000 Reduced 6.21%	287,002 Common Stock
Aug 12 2022	SELL Open market or private sale	$34,352 $4.04 p/Share	8,503 Reduced 2.7%	306,002 Common Stock
Aug 04 2022	SELL Open market or private sale	$70,590 $3.62 p/Share	19,500 Reduced 5.84%	314,505 Common Stock
Jun 28 2022	SELL Open market or private sale	$50,662 $3.47 p/Share	14,600 Reduced 4.19%	334,005 Common Stock
Apr 08 2022	BUY Grant, award, or other acquisition	$824,998 $4.62 p/Share	178,571 Added 33.87%	348,605 Common Stock
Mar 08 2022	SELL Open market or private sale	$56,726 $4.86 p/Share	11,672 Reduced 6.42%	170,034 Common Stock
Aug 16 2021	SELL Open market or private sale	$110,940 $11.85 p/Share	9,362 Reduced 4.9%	181,706 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	109,235 Added 36.37%	191,068 Common Stock

Also insider at

PTIXW

Protagenic Therapeutics, Inc.new ETFs

Director

RBS